Categories: All postsAnalysts

Take a pass on Freshii stock right now, Laurentian says

Health food and fast-casual restaurant franchise Freshii Inc. (Freshii Inc. Stock Quote, Chart, News: TSX:FRII) released its fourth quarter and year ended December 31, 2017, financial results on Thursday, with revenue arriving in-line with expectations, says Elizabeth Johnston, analyst with Laurentian Bank Securities, who gives a “Hold” rating to the stock.

Key numbers for Freshii’s Q4/17 had already been released in late January, with same store sales for the Toronto-based company up by 6.4 per cent in Q4 and 5.5 per cent for fiscal 2017. Freshii opened 25 net new stores in Q4, along with six closures and nine e-store openings (the company has 370 locations in the Americas and Europe).

Those numbers are in line with Johnston’s forecast, as were revenue of $5 million and adjusted EBITDA of $2.1 million for Q4 and adjusted EBITDA for fiscal 2017 of $7.2 million.

FRII began trading on the TSX in February of 2017, with the stock having lost half of its value over the past year. But management says things are looking up.

“We have learned a lot about operating in the public markets and have made progress towards driving our mission and building the start of an omni-channel brand,” says Matthew Corrin, Freshii Chairman and CEO in a press release today. “Our team’s focus on improving as each quarter has progressed is noticeable, and we are determined to carry that positive momentum into 2018.”

Johnston judges the investment impact of the Q4. “We rate Freshii a ‘Hold’ with a $7.00 target price, which is based on 14x our 2018 EBITDA estimate,” says the analyst.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: frii
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago